Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;104:3137-3144
doi: 10.1161/hc5001.100662
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mebazaa, A.
Right arrow Articles by Sys, S. U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mebazaa, A.
Right arrow Articles by Sys, S. U.
Related Collections
Right arrow Contractile function
Right arrow Other etiology

(Circulation. 2001;104:3137.)
© 2001 American Heart Association, Inc.


Basic Science Reports

Activation of Cardiac Endothelium as a Compensatory Component in Endotoxin-Induced Cardiomyopathy

Role of Endothelin, Prostaglandins, and Nitric Oxide

Alexandre Mebazaa, MD PhD; Gilles W. De Keulenaer, MD PhD; Xavier Paqueron, MD; Luc J. Andries, PhD; Philippe Ratajczak; Sophie Lanone, PhD; Christian Frelin, PhD; Dan Longrois, MD PhD; Didier Payen, MD PhD; Dirk L. Brutsaert, MD PhD; Stanislas U. Sys, MD PhD

From the Laboratoire d’Anesthöesiologie, Döepartement d’Anesthöesie-Röeanimation, INSERM U127, Hö.pital Lariboisière, Assistance Publique-Hö.pitaux de Paris, Institut Föedöeratif de Recherches Circulation, Universitöe Paris 7 Denis Diderot, Paris, France; Department of Physiology, University of Antwerp, Antwerp, Belgium; U408 INSERM, Facultöe Bichat, Paris, France; IPCM-CNRS UPR 411, Sophia Antipolis, France; and Döepartement d’Anesthöesie-Röeanimation, CHU de Brabois Nancy-Vandoeuvre, Nancy, France.

Correspondence to Alexandre Mebazaa, MD, PhD, Döepartement d’Anesthöesie-Röeanimation, Hö.pital Lariboisière, 2, Rue A. Paröe, 75475 Paris, Cedex 10, France. E-mail alexandre.mebazaa{at}lrb.ap-hop-paris.fr

Background In view of growing evidence of an important endothelial paracrine regulation of cardiac function, the present study investigated the role of cardiac endothelium-derived endothelin-1 (ET-1), prostaglandins, and nitric oxide (NO) during endotoxin-induced cardiomyopathy in rabbits.

Methods and Results Immunohistochemical studies showed a marked transient coinduction of the inducible isoforms of NO synthase (NOS-2) and cyclooxygenase (COX-2) in endocardial endothelium and coronary arteriolar endothelium of hearts 12 hours after intravenous administration of lipopolysaccharide (LPS+12h); staining for both isoforms was much weaker 24 hours later (LPS+36h). Nitrotyrosine localization was similar to that of NOS-2, suggesting a NOS-2–related endothelial formation of peroxynitrite in septic hearts. Contractile performance of papillary muscles was depressed in both LPS-treated groups. In the LPS+12h group, however, isometric twitches were significantly prolonged (482±14 versus 420±14 ms in the saline-treated group, P<0.005). This twitch prolongation was completely reversed by simultaneous administration of BQ-123 and indomethacin to block endogenous ET-1 and prostaglandins, respectively. In addition, in the LPS+12h group, myocardial inotropic responsiveness to exogenous ET-1 was enhanced (P<0.01).

Conclusions Cardiac endothelial activation and myocardial sensitization to endothelium-derived mediators may be part of an adaptive response in the early (12 hours) stages of septic cardiomyopathy.


Key Words: prostaglandins • endocardium • myocardium • nitric oxide synthase • infection




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
J.-L. Balligand, O. Feron, and C. Dessy
eNOS Activation by Physical Forces: From Short-Term Regulation of Contraction to Chronic Remodeling of Cardiovascular Tissues
Physiol Rev, April 1, 2009; 89(2): 481 - 534.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. G.F. Bronzwaer and W. J. Paulus
Nitric oxide: the missing lusitrope in failing myocardium
Eur. Heart J., October 2, 2008; 29(20): 2453 - 2455.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Konrad, M. Haney, G. Johansson, M. Wanecek, E. Weitzberg, and A. Oldner
Cardiac effects of endothelin receptor antagonism in endotoxemic pigs
Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H988 - H996.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
V. Mollace, C. Muscoli, E. Masini, S. Cuzzocrea, and D. Salvemini
Modulation of Prostaglandin Biosynthesis by Nitric Oxide and Nitric Oxide Donors
Pharmacol. Rev., June 1, 2005; 57(2): 217 - 252.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. Tuleja, F. Mejza, A. Cmiel, and A. Szczeklik
Effects of Cyclooxygenases Inhibitors on Vasoactive Prostanoids and Thrombin Generation at the Site of Microvascular Injury in Healthy Men
Arterioscler Thromb Vasc Biol, June 1, 2003; 23(6): 1111 - 1115.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
D. L. Brutsaert
Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity
Physiol Rev, January 1, 2003; 83(1): 59 - 115.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
I. V. Turko and F. Murad
Protein Nitration in Cardiovascular Diseases
Pharmacol. Rev., December 1, 2002; 54(4): 619 - 634.
[Abstract] [Full Text] [PDF]